摘要
目的探讨得普利麻(diprivan)为主的静脉复合麻醉在介入手术中的应用价值和安全性。方法65例患者80例次介入手术采用了非气管插管下得普利麻和芬太尼复合静脉麻醉,术中监测心率、血压、呼吸频率、脉搏、血氧饱和度(SaO2)及患者对介入操作的反应。结果65例患者80例次静脉麻醉均获成功,患者术中处于睡眠状态,无痛苦,对介入治疗过程无记忆。得普利麻用量(500±100)mg,芬太尼用量(0.200±0.025)mg。麻醉前后10 min平均动脉压分别为(11.4±2.2)kPa和(10.6±2.1)kPa,SaO2分别为(98±1.0)%和(96±1.5)%,均无显著性差异。结论非气管插管下的得普利麻和芬太尼复合静脉麻醉安全性好,能够达到无痛治疗、患者对手术过程无记忆的目的,值得推广应用。
Objective To evaluate the value and safety of Diprivan and Fentany intravenous administration of analgesia in interventional procedures. Methods Diprivan with Fentany intravenous administration for analgesia was used in eighty interventional procedures of sixty-five patients, without trackeal tube insertion, Vital signs including HR,BP,artefial oxygen saturation (SpO2) and patients' reaction to operating were recorded, Results Intravenous anesthesia was caried out successfully in eighty interventional procedures, with patients under sleeping condition during the operation, together with no pain and no agony memory of the procedure, The amount of Dipfivan was 500 ± 100 mg and Fentany was 0,2 ± 0,025 mg. Mean arterial pressure and SpO2 were 11.4 ± 2.2 kPa, 10.6 ± 2.1 kPa and 98 ± 1.0, 96 ± 1.5 respectively before and after ten minutes of the operation, with no significant difference. Conclusions Diprivan with Fentany intravenous administration for interventional procedure analgesia possess good safety, painless and no agony memmory of the proceduce; therefors ought to be recommanded.
出处
《介入放射学杂志》
CSCD
2006年第2期72-74,共3页
Journal of Interventional Radiology
基金
深圳市医学重点专科资助项目
关键词
得普利麻
芬太尼
介入治疗
静脉麻醉
无痛术
Diprivan
Fentany
Interventional procedures
Anesthesia
Analgesia